Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Artru · SciRah

Researcher profile · Semantic Scholar

P. Artru

Share profile

P. Artru — researcher profile on SciRah

h-index: 38
Works: 205
Citations: 8,753

Most-cited papers

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy, P. Hammel, M. Hebbar, M. Ben Abdelghani +28 more
2018New England Journal of Medicine2,321 citations Open access
Semantic Scholar
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
P. Hammel, F. Huguet, J. Van Laethem, D. Goldstein +10 more
2016Journal of the American Medical Association (JAMA)998 citations
Semantic Scholar
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
T. Conroy, F. Castan, A. Lopez, A. Turpin +14 more
2022JAMA Oncology316 citations Open access
Semantic Scholar
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
J. Bachet, O. Bouché, J. Taieb, O. Dubreuil +19 more
2018Annals of Oncology166 citations Open access
Semantic Scholar
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
D. Tougeron, G. Mouillet, I. Trouilloud, T. Lecomte +19 more
2016Journal of the National Cancer Institute164 citations
Semantic Scholar
Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.
T. Conroy, P. Hammel, M. Hebbar, M. Ben Abdelghani +16 more
2018Journal of Clinical Oncology149 citations
Semantic Scholar
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment
A. Thierry, S. El Messaoudi, C. Mollevi, J. Raoul +16 more
2017Annals of Oncology106 citations Open access
Semantic Scholar
Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
Corinne Frère, B. Bournet, S. Gourgou, J. Fraisse +83 more
2019Gastroenterology88 citations Open access
Semantic Scholar
How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort
D. Pietrasz, O. Turrini, V. Vendrely, J. Simon +15 more
2018Annals of Surgical Oncology82 citations
Semantic Scholar
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial
J. Bennouna, S. Hiret, A. Bertaut, O. Bouché +13 more
2019JAMA Oncology78 citations Open access
Semantic Scholar
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study
D. Tougeron, B. Sueur, A. Zaanan, C. Fouchardière +21 more
2020International Journal of Cancer77 citations Open access
Semantic Scholar
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
D. Vernerey, F. Huguet, A. Vienot, D. Goldstein +12 more
2016British Journal of Cancer67 citations Open access
Semantic Scholar
Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
N. Williet, A. Saint, Anne-Laure Pointet, D. Tougeron +14 more
2019Therapeutic Advances in Gastroenterology52 citations Open access
Semantic Scholar
Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study
J. Palle, D. Tougeron, A. Pozet, É. Soularue +24 more
2017OncoTarget43 citations Open access
Semantic Scholar
Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
D. Basile, C. Broudin, J. Emile, A. Falcoz +12 more
2022Annals of Oncology42 citations Open access
Semantic Scholar
BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases
J. Bachet, N. Moreno-López, L. Viganó, U. Marchese +20 more
2019British Journal of Surgery42 citations
Semantic Scholar
Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study.
C. Gallois, P. Artru, A. Lièvre, É. Auclin +8 more
2019European Journal of Cancer39 citations Open access
Semantic Scholar
Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology
M. Diouf, T. Filleron, Anne-Laure Pointet, A. Dupont-Gossard +13 more
2016Quality of Life Research34 citations
Semantic Scholar
Characteristics of BRAF V600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients.
C. de la Fouchardiére, R. Cohen, D. Malka, R. Guimbaud +16 more
2019The Oncologist32 citations Open access
Semantic Scholar
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial
R. Nicolle, J. Bachet, Alexandre Harlé, J. Iovanna +17 more
2023Journal of Clinical Oncology31 citations Open access
Semantic Scholar
NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)
A. Brouquet, J. Bachet, F. Huguet, M. Karoui +7 more
2020BMC Cancer29 citations Open access
Semantic Scholar
BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study
L. Mas, J. Bachet, V. Taly, O. Bouché +18 more
2019Cancers27 citations Open access
Semantic Scholar
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study.
J. Viaud, Clémence Brac, P. Artru, E. Le Pabic +6 more
2017Digestive and Liver Disease27 citations Open access
Semantic Scholar
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study
S. Javed, S. Benoist, P. Devos, S. Truant +10 more
2022World Journal of Surgical Oncology25 citations Open access
Semantic Scholar
Prognostic factors of Colorectal Cancer patients with Brain Metastases.
Pauline Roussille, M. Auvray, D. Vansteene, T. Lecomte +20 more
2021Radiotherapy and Oncology24 citations Open access
Semantic Scholar
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial.
A. Zaanan, O. Bouché, C. de la Fouchardiére, K. Le Malicot +17 more
2025The Lancet Oncology22 citations
Semantic Scholar
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
S. Pernot, O. Pellerin, P. Artru, C. Montérymard +10 more
2020British Journal of Cancer22 citations Open access
Semantic Scholar
Comparison of short course radiotherapy with chemoradiotherapy for locally advanced rectal cancers in the elderly: A multicentre, randomised, non-blinded, phase 3 trial.
E. François, B. De Bari, P. Ronchin, É. Nouhaud +11 more
2022European Journal of Cancer21 citations Open access
Semantic Scholar
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.
J. Bachet, P. Laurent-Puig, A. Meurisse, O. Bouché +17 more
2023European Journal of Cancer18 citations Open access
Semantic Scholar
Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD.
T. Aparicio, A. Darut‐Jouve, F. Khemissa-Akouz, C. Montérymard +18 more
2020Journal of Geriatric Oncology18 citations Open access
Semantic Scholar
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.
G. Lledo, F. Huguet, B. Chibaudel, F. Di Fiore +12 more
2016European Journal of Cancer18 citations
Semantic Scholar
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
J. Taieb, J. Souglakos, I. Boukovinas, A. Falcoz +18 more
2025Journal of Clinical Oncology17 citations Open access
Semantic Scholar
Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study.
C. Gallois, C. Bourillon, É. Auclin, P. Artru +8 more
2021Clinics And Research in Hepatology and Gastroenterology17 citations Open access
Semantic Scholar
LBA57 Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC)
T. Conroy, P. Hammel, A. Turpin, C. Belletier +16 more
2021Annals of Oncology16 citations Open access
Semantic Scholar
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study.
Anne-Laure Pointet, D. Tougeron, S. Pernot, A. Pozet +11 more
2020Clinics And Research in Hepatology and Gastroenterology16 citations Open access
Semantic Scholar
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High‐Risk Stage III (pT4 and/or N2) Colon Cancer—A UNICANCER GI‐PRODIGE Trial
J. Bennouna, T. André, L. Campion, S. Hiret +14 more
2019Clinical colorectal cancer16 citations Open access
Semantic Scholar
A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort
C. Canivet, S. Gourgou-Bourgade, B. Napoléon, Laurent Palazzo +82 more
2018BMC Cancer16 citations Open access
Semantic Scholar
A large multicenter study evaluating prognosis and chemosensitivity of metastatic colorectal cancers with microsatellite instability.
D. Tougeron, B. Sueur, D. Sefrioui, L. Gentilhomme +16 more
201716 citations
Semantic Scholar
Rectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, and GRECCAR).
Eddy Cotte, Justine Arquillière, P. Artru, J. Bachet +13 more
2024Digestive and Liver Disease15 citations Open access
Semantic Scholar
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
S. Zaibet, V. Hautefeuille, É. Auclin, A. Lièvre +11 more
2022British Journal of Cancer15 citations Open access
Semantic Scholar
RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014.
A. Lièvre, J. Merlin, J. Sabourin, P. Artru +8 more
2018Digestive and Liver Disease15 citations Open access
Semantic Scholar
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
D. Tougeron, L. Dahan, L. Evesque, K. Le Malicot +24 more
2024JAMA Oncology14 citations Open access
Semantic Scholar
533PA large retrospective multicenter study evaluating prognosis and chemosensitivity of metastatic colorectal cancer with microsatellite instability
D. Tougeron, Régis Cohen, Benjamin Sueur, D. Sefrioui +16 more
201713 citations Open access
Semantic Scholar
477OBevacizumab (Bev) or cetuximab (Cet) plus chemotherapy after progression with bevacizumab plus chemotherapy in patients with wild-type (WT) KRAS metastatic colorectal cancer (mCRC): Final analysis of a French randomized, multicenter, phase II study (PRODIGE 18)
J. Bennouna, S. Hiret, C. Borg, A. Bertaut +12 more
201712 citations Open access
Semantic Scholar
Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study.
F. Mary, A. Zaanan, V. Boige, P. Artru +12 more
2016Digestive and Liver Disease12 citations
Semantic Scholar
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter Study.
M. Auvray, D. Tougeron, É. Auclin, V. Moulin +11 more
2020Clinical colorectal cancer11 citations
Semantic Scholar
Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study
A. Zaanan, J. Palle, É. Soularue, F. Leroy +6 more
2018Targeted oncology11 citations
Semantic Scholar
RAS mutations concordance in circulating tumor DNA (ctDNA) and tissue in metastatic colorectal cancer (mCRC): RASANC, an AGEO prospective multicenter study.
J. Bachet, O. Bouché, Julien Taïeb, O. Dubreuil +16 more
201711 citations
Semantic Scholar
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective
C. Neuzillet, P. Artru, E. Assenat, J. Edeline +5 more
2023Targeted oncology10 citations Open access
Semantic Scholar
Efficacy of EUS-guided hepaticogastrostomy in prolonging survival of patients with perihilar cholangiocarcinoma
A. Schoch, A. Lisotti, T. Walter, F. Fumex +7 more
2022Endoscopic Ultrasound9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Tougeron×19
Invite
D. Tougeron — researcher profile on SciRah
J. Taieb×17
Invite
J. Taieb — researcher profile on SciRah
T. Lecomte×16
Invite
T. Lecomte — researcher profile on SciRah
J. Bachet×14
Invite
J. Bachet — researcher profile on SciRah

×12

Invite

O. Bouché — researcher profile on SciRah

Invite

R. Coriat — researcher profile on SciRah

Invite

A. Zaanan — researcher profile on SciRah

V. Hautefeuille×11

Invite

V. Hautefeuille — researcher profile on SciRah

C. de la Fouchardiére×10

Invite

C. de la Fouchardiére — researcher profile on SciRah

Invite

T. Aparicio — researcher profile on SciRah

Invite

D. Vernerey — researcher profile on SciRah

C. Lécaille×8

Invite

C. Lécaille — researcher profile on SciRah